Strides Pharma recalls 25mg Losartan tablets with blue plastic piece
Strides Pharma recalls 25mg Losartan Potassium Tablets due to small blue plastic piece in some tablets. Rx-only medication sold in India with specific lot number.
Lower-risk recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Contact the company
What happened, in plain English
Strides Pharma is recalling 25mg Losartan Potassium Tablets that may contain a small blue plastic piece. This foreign substance could cause injury if swallowed. The recall affects prescription-only medication sold in India with specific lot numbers. Read more at govinfonow.com/recall/33398-strides-pharma-recalls-25mg-losartan-tablets-with-blue-plastic-piece.
Source Summary by GovInfoNow · govinfonow.com/recall/33398-strides-pharma-recalls-25mg-losartan-tablets-with-blue-plastic-piece · Updated August 17, 2026 · FDA enforcement record: FDA #D-0895-2023
Cite this page
“Strides Pharma recalls 25mg Losartan tablets with blue plastic piece.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/33398-strides-pharma-recalls-25mg-losartan-tablets-with-blue-plastic-piece. Based on FDA recall #D-0895-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0895-2023%22&limit=1).
Why it’s dangerous
A small piece of blue plastic can be embedded in the tablet. If swallowed, it could cause choking or internal injury. However, the risk is low because the plastic piece is small and the tablets are prescription-only.
Who’s affected
Prescription-only Losartan tablets sold in India with lot number 7901903A (expiring April 2024) are affected. People taking this medication for high blood pressure are most at risk.
How to tell if you have this one
Check for the product name 'Losartan Potassium Tablets, USP, 25 mg' on the bottle. Look for the lot number 7901903A on the label. The tablets were sold in India with an expiration date of April 2024.
- Brand
Strides Pharma- Category
Drug
What to do — step by step
Check for Plastic Piece
Inspect the tablet for a small blue plastic piece before taking it.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 11 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What should I do if I have this product?
Check for a blue plastic piece. If present, do not take it. Contact your doctor for advice.
Similar recalls
Other Strides Pharma recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0895-2023 (June 26, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0895-2023 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.